There were no statistically significant differences in adverse effects , length of hospitalisation or mortality .
Conclusion Oral iron raises haemoglobin levels in elderly people with iron deficiency anaemia by 0.35 g/dL after 4–6 weeks , but it is unclear if this results in tangible health benefits
Background Oral iron supplementation is used widely in older people despite observational studies suggesting it is ineffective .
Objective The aim of this systematic review was to determine if oral iron therapy is effective in elderly people with iron deficiency anaemia .
Iron supplementation after femoral head replacement for patients with normal iron stores.
OBJECTIVE To assess the efficacy of oral iron therapy in the recovery of patients ' hemoglobin levels after major surgery . DESIGN R and omized controlled trial . SETTING Private orthopedic practice confined to one large community hospital . PATIENTS One hundred seventy consecutive elderly patients undergoing hip surgery ; 75 failed to meet entry hematologic or medical criteria ; 95 were r and omized , with 16 withdrawn because of complications . INTERVENTION Thirty-seven patients received ferrous sulfate orally four times a day for the duration of their hospitalization . Forty-two patients who received no iron supplement served as the control group . MAIN OUTCOME MEASURES Changes in hemoglobin levels and reticulocyte counts over the 2- to 3-week follow-up period . RESULTS There was no significant difference in mean hemoglobin levels between the treatment and control groups ( 95 % confidence interval [ CI ] for difference of -6.6 to 5.4 g/L ) . Corrected reticulocyte fractions increased equally in both groups ( 95 % CI for difference of -9 x 10(3 ) to 2 x 10(-3 ) . The study was design ed to detect a difference in mean hemoglobin levels of 8.5 g/L or greater or a difference in mean reticulocyte fraction of 10 x 10(-3 ) between the two groups with a power of 0.80 at the .05 ( two-sided ) level of significance . CONCLUSION The administration of oral iron supplements to elderly , healthy orthopedic patients postoperatively did not hasten the recovery of hemoglobin levels , provided adequate tissue iron stores were present
There were no statistically significant differences in adverse effects , length of hospitalisation or mortality .
Conclusion Oral iron raises haemoglobin levels in elderly people with iron deficiency anaemia by 0.35 g/dL after 4–6 weeks , but it is unclear if this results in tangible health benefits
Background Oral iron supplementation is used widely in older people despite observational studies suggesting it is ineffective .
Objective The aim of this systematic review was to determine if oral iron therapy is effective in elderly people with iron deficiency anaemia .